MARC Record from marc_columbia

LEADER: 02172fam a2200361 a 4500
001 4052314
005 20221027024842.0
008 950717t19961996enka b 001 0 eng c
010 $a 95034951
020 $a0471948470 (alk. paper)
035 $a(OCoLC)32925948
035 $a(OCoLC)ocm32925948
035 $9ALT2863HS
035 $a(NNC)4052314
035 $a4052314
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M$dOrLoB-B
050 00 $aRS420$b.S66 1995
060 10 $aQV 744 S671d 1995
082 00 $a615/.19$220
100 1 $aSneader, Walter.$0http://id.loc.gov/authorities/names/n84205729
245 10 $aDrug prototypes and their exploitation /$cWalter Sneader.
260 $aChichester ;$aNew York :$bWiley,$c[1996], ©1996.
300 $axii, 788 pages :$billustrations ;$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $gCh. 1.$tSources of Drug Prototypes --$gCh. 2.$tMinerals and Inorganic Chemicals --$gCh. 3.$tAlkaloids --$gCh. 4.$tNon-alkaloidal Plant Products --$gCh. 5.$tLow Molecular Weight Hormones and Related Substances --$gCh. 6.$tSteroid Hormones --$gCh. 7.$tPeptide Hormones --$gCh. 8.$tProstaglandins --$gCh. 9.$tBlood and Other Body Fluids --$gCh. 10.$tGrowth Factors and Cytokines --$gCh. 11.$tVitamins --$gCh. 12.$tNucleic Acids --$gCh. 13.$tSnake Venom --$gCh. 14.$tSponge Product --$gCh. 15.$tAntibiotics --$gCh. 16.$tPharmacodynamic Agents from Micro-organisms --$gCh. 17.$tSynthetic Compounds with Chemotherapeutic Activity --$gCh. 18.$tSynthetic Compounds with Pharmacodynamic Activity --$gCh. 19.$tSerendipity I: Effects Perceived by Observers --$gCh. 20.$tSerendipity II: Effects Observed during Laboratory Experiments.
650 0 $aDrugs$xDesign.$0http://id.loc.gov/authorities/subjects/sh88001157
650 0 $aDrugs$xDerivatives.$0http://id.loc.gov/authorities/subjects/sh86006024
650 12 $aDrug Design.$0https://id.nlm.nih.gov/mesh/D015195
650 22 $aDrug Compounding.$0https://id.nlm.nih.gov/mesh/D004339
650 22 $aBiological Availability.$0https://id.nlm.nih.gov/mesh/D001682
852 00 $boff,hsl$hRS420$i.S66 1996